Literature DB >> 28670072

Primary mucoepidermoid carcinoma of the lung with prominent clear cells.

David D Fink1, Angela M Lomas1, Anja C Roden1, Prashant C Shah1, Riyam T Zreik1.   

Abstract

Mucoepidermoid carcinoma of the lung is a rare malignancy of salivary gland-type origin. We report a case of a 21-year-old man with a right mainstem bronchus mass composed predominantly of clear cells. This case represents a rare primary pulmonary low-grade mucoepidermoid carcinoma positive for MAML2 rearrangement by fluorescence in situ hybridization with a prominent clear cell component.

Entities:  

Year:  2017        PMID: 28670072      PMCID: PMC5468030          DOI: 10.1080/08998280.2017.11929633

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  17 in total

1.  Bronchogenic carcinoma; an analysis of 100 autopsy cases.

Authors:  H F SMETANA; L IVERSON; L L SWAN
Journal:  Mil Surg       Date:  1952-11

2.  Mucoepidermoid carcinoma of the palate composed exclusively of clear cells (clear cell variant).

Authors:  Tadashi Terada; Shinobu Ikeuchi; Chie Inomoto; Kazuo Shimamura
Journal:  Virchows Arch       Date:  2004-07-29       Impact factor: 4.064

3.  Conjunctival mucoepidermoid carcinoma: clear cell variant.

Authors:  Rashmi Kapur; Joel Sugar; Deepak P Edward
Journal:  Arch Ophthalmol       Date:  2005-09

Review 4.  Review and updates of immunohistochemistry in selected salivary gland and head and neck tumors.

Authors:  Shaobo Zhu; Conrad Schuerch; Jennifer Hunt
Journal:  Arch Pathol Lab Med       Date:  2015-01       Impact factor: 5.534

5.  A clear cell variant of mucoepidermoid carcinoma harboring CRTC1-MAML2 fusion gene found in buccal mucosa: report of a case showing a large clear cell component and lacking typical epidermoid cells and intermediate cells.

Authors:  Shogo Tajima; Ichiro Namiki; Kenji Koda
Journal:  Med Mol Morphol       Date:  2015-08-22       Impact factor: 2.309

6.  Prognostic factors of primary pulmonary mucoepidermoid carcinoma: a clinical and pathological analysis of 34 cases.

Authors:  Li Jiang; Pengfei Li; Zizheng Xiao; Huijuan Qiu; Xinke Zhang; Yongbo Xiao; Bei Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

7.  Mucoepidermoid tumors of the lung.

Authors:  S A Yousem; L Hochholzer
Journal:  Cancer       Date:  1987-09-15       Impact factor: 6.860

8.  Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading.

Authors:  M S Brandwein; K Ivanov; D I Wallace; J J Hille; B Wang; A Fahmy; C Bodian; M L Urken; D R Gnepp; A Huvos; H Lumerman; S E Mills
Journal:  Am J Surg Pathol       Date:  2001-07       Impact factor: 6.394

9.  EGFR L861Q mutation is a frequent feature of pulmonary mucoepidermoid carcinoma.

Authors:  Yongfeng Yu; Zhengbo Song; Hui Gao; Lei Zhu; Shun Lu; Jie Zhang; Qingquan Luo
Journal:  J Cancer Res Clin Oncol       Date:  2012-04-18       Impact factor: 4.553

10.  t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway.

Authors:  Giovanni Tonon; Sanjay Modi; Lizi Wu; Akihito Kubo; Amy B Coxon; Takefumi Komiya; Kevin O'Neil; Kristen Stover; Adel El-Naggar; James D Griffin; Ilan R Kirsch; Frederic J Kaye
Journal:  Nat Genet       Date:  2003-01-21       Impact factor: 38.330

View more
  3 in total

1.  Challenges in diagnosis of pulmonary mucoepidermoid carcinoma: A case report.

Authors:  Xiangxiang Zhou; Min Zhang; Xingyan Yan; Yulan Zhong; Siyun Li; Jixiang Liu; Linfeng Peng; Xin Gan
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

2.  Metastatic mucoepidermoid carcinoma to the pleura: a case report.

Authors:  Simran Mashiana; Ernesto Martinez Duarte
Journal:  J Med Case Rep       Date:  2022-02-16

Review 3.  Primary lung hyalinizing clear cell carcinoma: a diagnostic challenge in biopsy.

Authors:  Yanling Zhang; Wen Han; Jun Zhou; Xiang Yong
Journal:  Diagn Pathol       Date:  2022-03-27       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.